{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:09:14Z","timestamp":1780085354431,"version":"3.54.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005037","name":"Bo\u011fazi\u00e7i University","doi-asserted-by":"publisher","award":["25B07P1"],"award-info":[{"award-number":["25B07P1"]}],"id":[{"id":"10.13039\/501100005037","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110650","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:32:16Z","timestamp":1755822736000},"page":"110650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Antidepressant ketamine via oral gavage impairs fear memory, suppresses 22\u00a0kHz ultrasonic vocalizations, lowers GluN2A\/B expression, and reduces medial habenula activity in rats"],"prefix":"10.1016","volume":"279","author":[{"given":"Beenish","family":"Asrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sude","family":"Metin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-0271","authenticated-orcid":false,"given":"Gunes","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56850-6","article-title":"Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression","volume":"16","author":"Aboharb","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110650_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114594","article-title":"A shea butter-based ketamine ointment: the antidepressant effects of transdermal ketamine in rats","volume":"452","author":"Akan","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110650_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100239","article-title":"The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice","volume":"13","author":"Anderzhanova","year":"2020","journal-title":"Neurobiology of Stress"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib4","article-title":"Oral ketamine for depression, 2: practical considerations","volume":"80","author":"Andrade","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central Mammalian neurones by N\u2010methyl\u2010aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/bja\/77.5.625","article-title":"Effect of racemic mixture and the (S+)-isomer of ketamine on temporal and spatial summation of pain","volume":"77","author":"Arendt-Nielsen","year":"1996","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2025.110650_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173790","article-title":"Environmental enrichment enhances the antidepressant effect of ketamine and ameliorates spatial memory deficits in adult rats","volume":"240","author":"Aykan","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine's antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/02698811241301215","article-title":"Ketamine for treatment-resistant obsessive-compulsive disorder: double-Blind active-controlled crossover study","volume":"39","author":"Beaglehole","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110650_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/ph17101265","article-title":"NMDA receptors: distribution, role, and insights into neuropsychiatric disorders","volume":"17","author":"Beaurain","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2025.110650_bib12","author":"Bitter"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0031-9384(91)90423-L","article-title":"Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems","volume":"50","author":"Blanchard","year":"1991","journal-title":"Physiol. Behav."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110650_bib14","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","article-title":"Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability","volume":"26","author":"Bonaventura","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110650_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.08.038","article-title":"Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms","volume":"126","author":"Botanas","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1570159X13999150210141444","article-title":"Pharmacology of ultrasonic vocalizations in adult rats: significance, call classification and neural substrate","volume":"13","author":"Brudzynski","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2025.110650_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2013.04.022","article-title":"Rats selectively bred for low levels of play-induced 50kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors","volume":"251","author":"Burgdorf","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110650_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","article-title":"Sex differences in the antidepressant-like effects of ketamine","volume":"70","author":"Carrier","year":"2013","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110650_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41386-020-0714-z","article-title":"Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-Hydroxynorketamine","volume":"45","author":"Chen","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/j.neuropharm.2025.110650_bib20","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.3390\/ijms21197173","article-title":"Effects of ketamine on rodent fear memory","volume":"21","author":"Choi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00044011-200929050-00004","article-title":"Development of a sublingual\/oral formulation of ketamine for use in neuropathic pain","volume":"29","author":"Chong","year":"2009","journal-title":"Clin. Drug Invest."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans","volume":"71","author":"Clements","year":"1982","journal-title":"J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41386-018-0303-6","article-title":"DeepSqueak: a deep learning-based system for detection and analysis of ultrasonic vocalizations","volume":"44","author":"Coffey","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bjp.2018.196","article-title":"Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"214","author":"Domany","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110650_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuropharm.2016.06.022","article-title":"Prediction of individual differences in fear response by novelty seeking, and disruption of contextual fear memory reconsolidation by ketamine","volume":"109","author":"Duclot","year":"2016","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110650_bib28","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s00213-023-06480-x","article-title":"Oral ketamine May offer a solution to the ketamine conundrum","volume":"240","author":"Dutton","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110650_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112058","article-title":"Oral ketamine alleviates behavioral despair without cognitive impairment in wistar rats","volume":"372","author":"Ecevitoglu","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110650_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00228-015-1826-y","article-title":"Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing","volume":"71","author":"Fanta","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib31","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110650_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215554","article-title":"Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test","volume":"14","author":"Fitzgerald","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110650_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","article-title":"Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \u201cdepressed\u201d mice exposed to chronic mild stress","volume":"290","author":"Franceschelli","year":"2015","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib34","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-Blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"J. Clin. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1124\/dmd.117.078360","article-title":"Ketamine pharmacokinetics and pharmacodynamics are altered by P-Glycoprotein and breast cancer resistance protein efflux transporters in mice","volume":"46","author":"Ganguly","year":"2018","journal-title":"Drug Metabol. Dispos.: The Biological Fate of Chemicals"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","article-title":"Rodent tests of depression and anxiety: construct validity and translational relevance","volume":"24","author":"Gencturk","year":"2024","journal-title":"Cognit. Affect Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib37","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2025.110650_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.026","article-title":"Ketamine accelerates fear extinction via mTORC1 signaling","volume":"100","author":"Girgenti","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ph17060669","article-title":"Ketamine's amelioration of fear extinction in adolescent Male mice is associated with the activation of the hippocampal Akt-mTOR-GluA1 pathway","volume":"17","author":"Glavonic","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib40","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41591-024-03063-x","article-title":"Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial","volume":"30","author":"Glue","year":"2024","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00213-024-06571-3","article-title":"The role of mGluR5 on the therapeutic effects of ketamine in wistar rats","volume":"241","author":"Gokalp","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110650_bib42","series-title":"Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests","author":"Gould","year":"2009"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110650_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/bja\/53.8.805","article-title":"Pharmacokinetics and analgesic effects of i.m. and oral ketamine","volume":"53","author":"Grant","year":"1981","journal-title":"Br. J. Anaesth."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110650_bib44","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1526-4637.2011.01199.x","article-title":"Does ketamine improve postoperative analgesia? More questions than answers","volume":"12","author":"Grathwohl","year":"2011","journal-title":"Pain Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110650_bib46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3758\/s13415-022-00989-y","article-title":"The differential effects of brief environmental enrichment following social isolation in rats","volume":"22","author":"Guven","year":"2022","journal-title":"Cognit. Affect Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-024-06448-x","article-title":"Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study","volume":"25","author":"Halpape","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269881118812095","article-title":"Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-hydroxynorketamine","volume":"33","author":"Highland","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pbb.2007.09.005","article-title":"Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs","volume":"88","author":"Hodgson","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"34","key":"10.1016\/j.neuropharm.2025.110650_bib50","doi-asserted-by":"crossref","first-page":"11366","DOI":"10.1523\/JNEUROSCI.1861-14.2014","article-title":"Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement","volume":"34","author":"Hsu","year":"2014","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110650_bib51","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1038\/npp.2015.100","article-title":"Observation of distressed conspecific as a model of emotional trauma generates silent synapses in the prefrontal-amygdala pathway and enhances fear learning, but ketamine abolishes those effects","volume":"40","author":"Ito","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110650_bib52","article-title":"Biomarkers in an animal model for revealing neural, hematologic, and behavioral correlates of PTSD","volume":"68","author":"Jia","year":"2012","journal-title":"JoVE J."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110650_bib53","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/npp.2014.123","article-title":"The role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling schizophrenia and treating refractory depression","volume":"39","author":"Jim\u00e9nez-S\u00e1nchez","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"20","key":"10.1016\/j.neuropharm.2025.110650_bib54","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0024-3205(98)00450-0","article-title":"Effect of analgesics on audible and ultrasonic pain-induced vocalization in the rat","volume":"63","author":"Jourdan","year":"1998","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib55","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000542-199212000-00022","article-title":"Metabolism of ketamine stereoisomers by human liver microsomes","volume":"77","author":"Kharasch","year":"1992","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110650_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015077","article-title":"Social transmission of fear in rats: the role of 22-kHz ultrasonic distress vocalization","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110650_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109468","article-title":"Chronic oral ketamine prevents anhedonia and alters neuronal activation in the lateral habenula and nucleus accumbens in rats under chronic unpredictable mild stress","volume":"228","author":"Kingir","year":"2023","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.20240378","article-title":"Redefining ketamine pharmacology for antidepressant action: synergistic NMDA and opioid receptor interactions?","volume":"182","author":"Levinstein","year":"2025","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110650_bib60","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2022.12.019","article-title":"Mu opioid receptor activation mediates (S)-ketamine reinforcement in rats: implications for abuse liability","volume":"93","author":"Levinstein","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"5994","key":"10.1016\/j.neuropharm.2025.110650_bib61","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2025.110650_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2024.173891","article-title":"(2R,6R)-Hydroxynorketamine alleviates PTSD-Like endophenotypes by regulating the PI3K\/AKT signaling pathway in rats","volume":"245","author":"Liu","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020484","article-title":"Advances in oral drug delivery systems: challenges and opportunities","volume":"15","author":"Lou","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1152\/jn.1987.58.2.251","article-title":"Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine","volume":"58","author":"MacDonald","year":"1987","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib65","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/jm00326a019","article-title":"The synthesis of phencyclidine and other 1-Arylcyclohexylamines","volume":"8","author":"Maddox","year":"1965","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bja\/77.2.203","article-title":"Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children","volume":"77","author":"Malinovsky","year":"1996","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00132586-197612000-00013","article-title":"Biodisposition of ketamine in the rat","volume":"20","author":"Marietta","year":"1976","journal-title":"Surv. Anesthesiol."},{"key":"10.1016\/j.neuropharm.2025.110650_bib68","article-title":"Prophylactic (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine decrease fear expression by differentially modulating fear neural ensembles","author":"Mastrodonato","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110650_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jnc.14008","article-title":"The medial habenula and interpeduncular nucleus circuitry is critical in addiction, anxiety, and mood regulation","volume":"142","author":"McLaughlin","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110650_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"eLife"},{"issue":"6462","key":"10.1016\/j.neuropharm.2025.110650_bib73","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1126\/science.aax1522","article-title":"Control of aversion by glycine-gated GluN1\/GluN3A NMDA receptors in the adult medial habenula","volume":"366","author":"Otsu","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110650_bib74","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)11430-4","article-title":"Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors","volume":"260","author":"Oye","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib75","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110650_bib76","series-title":"The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition","author":"Paxinos","year":"2006"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib77","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1472-8206.2011.00954.x","article-title":"St John's wort greatly decreases the plasma concentrations of oral S-ketamine","volume":"26","author":"Peltoniemi","year":"2012","journal-title":"Fund. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110650_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cns.12111","article-title":"Ketamine in pain management","volume":"19","author":"Persson","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib79","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.pnpbp.2006.02.019","article-title":"Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat","volume":"30","author":"Pietersen","year":"2006","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110650_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.06.001","article-title":"Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice","volume":"46","author":"Poleszak","year":"2013","journal-title":"Progress. neuro psychopharmacol. biological psychiatr"},{"key":"10.1016\/j.neuropharm.2025.110650_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2025.04.020","article-title":"Ketamine evokes acute behavioral effects via \u03bc opioid receptor\u2013expressing neurons of the central amygdala","author":"Pomrenze","year":"2025","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110650_bib82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12640-017-9759-0","article-title":"Comparison of the psychopharmacological effects of tiletamine and ketamine in rodents","volume":"32","author":"Popik","year":"2017","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41398-018-0310-8","article-title":"Enhanced fear memories and brain glucose metabolism (18F-FDG-PET) following sub-anesthetic intravenous ketamine infusion in sprague-dawley rats","volume":"8","author":"Radford","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110650_bib84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2016.12.014","article-title":"Dose-response characteristics of intravenous ketamine on dissociative stereotypy, locomotion, sensorimotor gating, and nociception in Male sprague-dawley rats","volume":"153","author":"Radford","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110650_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112259","article-title":"Association between intravenous ketamine-induced stress hormone levels and long-term fear memory renewal in sprague-dawley rats","volume":"378","author":"Radford","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110650_bib86","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170976","article-title":"Laryngeal airway reconstruction indicates that rodent ultrasonic vocalizations are produced by an edge-tone mechanism","volume":"4","author":"Riede","year":"2017","journal-title":"R. Soc. Open Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib87","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/npp.2011.155","article-title":"The Mu-Opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control","volume":"37","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110650_bib89","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuropharm.2015.07.037","article-title":"Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: role of activity at NMDA receptor","volume":"99","author":"Sa\u0142at","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110650_bib90","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2399\/ana.11.212","article-title":"A simple method for isolation of the anteroventral periventricular and arcuate nuclei of the rat hypothalamus","volume":"6\u20137","author":"Salehi","year":"2013","journal-title":"Anatomy (International Journal of Experimental and Clinical Anatomy)"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib92","first-page":"68","article-title":"Evaluation of ketamine HCl for anti-depressant activity","volume":"214","author":"Sofia","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110650_bib93","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuron.2015.08.035","article-title":"Habenular CB1 receptors control the expression of aversive memories","volume":"88","author":"Soria-G\u00f3mez","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib94","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-022-02434-w","article-title":"Effects of an intravenous ketamine infusion on inflammatory cytokine levels in Male and female Sprague-Dawley rats","volume":"19","author":"Spencer","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110650_bib95","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/mp.2011.171","article-title":"Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology","volume":"17","author":"Stone","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib96","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","article-title":"Cellpose: a generalist algorithm for cellular segmentation","volume":"18","author":"Stringer","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2025.110650_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114792","article-title":"Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala","volume":"459","author":"Teng","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib98","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-023-42315-1","article-title":"Thalamic nucleus reuniens coordinates prefrontal-hippocampal synchrony to suppress extinguished fear","volume":"14","author":"Totty","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(92)90248-3","article-title":"Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons","volume":"213","author":"Ulrich Zeilhofer","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110650_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112047","article-title":"Psychomotor retardation in depression: a critical measure of the forced swim test","volume":"372","author":"Unal","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110650_bib101","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nlm.2014.12.012","article-title":"Prefrontal NMDA receptors expressed in excitatory neurons control fear discrimination and fear extinction","volume":"119","author":"Vieira","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2025.110650_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115273","article-title":"(2R, 6R)-hydroxynorketamine ameliorates PTSD-like behaviors during the reconsolidation phase of fear memory in rats by modulating the VGF\/BDNF\/GluA1 signaling pathway in the hippocampus","volume":"476","author":"Wang","year":"2025","journal-title":"Behav. Brain Res."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110650_bib103","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41380-019-0503-4","article-title":"Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism","volume":"24","author":"Williams","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110650_bib104","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110650_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109402","article-title":"(2R,6R)-hydroxynorketamine targeting the basolateral amygdala regulates fear memory","volume":"225","author":"Xu","year":"2023","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110650_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharm Drug Dispos."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110650_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110650_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172876","article-title":"(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression","volume":"191","author":"Yokoyama","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2025.110650_bib109","article-title":"Ketamine differentially affects implicit and explicit memory processes in rats","author":"Yuksel","year":"2024","journal-title":"Psychopharmacology"},{"issue":"7604","key":"10.1016\/j.neuropharm.2025.110650_bib111","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110650_bib112","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110650_bib113","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2017.05.067","article-title":"The effect of hippocampal NMDA receptor blockade by MK-801 on cued fear extinction","volume":"332","author":"Zhang","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110650_bib114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110650_bib115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3758\/s13415-023-01118-z","article-title":"Age-related impairment in fear memory extinction is restored by ketamine in middle-aged mice","volume":"23","author":"Zhao","year":"2023","journal-title":"Cognit. Affect Behav. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:11:44Z","timestamp":1780027904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":107,"alternative-id":["S0028390825003582"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110650","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant ketamine via oral gavage impairs fear memory, suppresses 22\u00a0kHz ultrasonic vocalizations, lowers GluN2A\/B expression, and reduces medial habenula activity in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110650"}}